MedPath

A Structuralised Sick-leave Program Compared to Usual Care Sick Leave Management in Patients After an Acute Myocardial Infarction

Not Applicable
Conditions
Myocardial Infarction
Interventions
Other: Usual care sick-leave management
Other: Structuralised sick-leave program
Registration Number
NCT01108653
Lead Sponsor
Oslo University Hospital
Brief Summary

In this study the investigators aim at comparing the effect on quality of life and the cost-effectiveness of a structuralised sick-leave program compared to usual care sick leave management in patients after an acute non ST myocardial infarction(NSTEMI).The investigators hypothesize that a structuralised sick-leave program after an acute NSTEMI is cost-effective without a negative effect on quality of life compared to usual care management in this patient group.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Patients with acute NSTEMI who are revascularized.
  • 65 years old or less
  • Self caring
  • Adequately literate in Norwegian
  • Have a regular work in at least 50% position.
Exclusion Criteria
  • Patients not willing to participate
  • Professional drivers
  • Patients with alcohol or drug abuse
  • Severe complications after the myocardial infarction such as malignant arrythmias, heart failure and major bleedings.
  • Patients with recent CABG ( coronary artery bypass graft operation) within the last 6 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 1: Usual care sick-leave managementUsual care sick-leave management-
Group 2: Structuralised sick-leave programStructuralised sick-leave program-
Primary Outcome Measures
NameTimeMethod
Cost effectivenessone year

In order to evaluate resource use (costs) all patients will be asked to fill in a questionnaire at baseline and after 6 and 12 months. Total costs and mean costs will be calculated in the two different follow-up modalities.

Secondary Outcome Measures
NameTimeMethod
Quality of Life measures are estimated at baseline and after 6 and 12 months using the standard Medical Outcomes Study Short form( SF-36)questionnaire and the disease-specific Utility-Based Quality of life-Heart questionnaire(UBQ-H).one year

Trial Locations

Locations (1)

Oslo University Hospital

🇳🇴

Oslo, Trondheimsveien 235, Norway

© Copyright 2025. All Rights Reserved by MedPath